Latest Patents News

Entropy Neurodynamics has dosed its third patient with TRP-8803 in a Binge Eating Disorder trial, achieving a full and controlled psychedelic response that underscores the drug’s potential for precise therapeutic delivery.

Metal Powder Works has independently confirmed its DirectPowder™ CP Titanium Grade 2 feedstock meets stringent ASTM B384 structural standards via Laser Powder Bed Fusion, reinforcing its position in aerospace additive manufacturing.

Vectus Biosystems has completed the sale of its VB4-P5 renal fibrosis compound to Canadian biotech XORTX, receiving a near 10% equity stake and warrants. This move aligns with Vectus’ strategy to develop drug candidates to a stage attractive to partners while focusing on its lead compound VB0004.

6K Additive has secured a $3.9 million U.S. defense contract modification to expand domestic production of strategic tungsten and niobium powders, reinforcing supply chain resilience amid geopolitical risks.

WhiteHawk (ASX: WHK) has acquired Quixxi, gaining the Clarity AI platform to extend its cybersecurity services into the burgeoning global AI governance sector. The deal positions WhiteHawk at the convergence of cybersecurity, data governance, and AI risk management amid rapid market growth and regulatory momentum.

Pacific Edge reported a 2.7% increase in test volumes for Q4 2026 despite operational challenges, supported by growing momentum toward Medicare coverage and expanded commercial payer adoption in the US and Asia Pacific.

American Rare Earths has outlined a three-stage pilot plant program combining Wyoming-based mineral processing with downstream refining in Canada, aiming to accelerate pre-production rare earth oxide output from its Halleck Creek Project.

Marquee Resources has entered a 24-month patent license and option agreement with UT-Battelle LLC, granting access to advanced rare earth element separation technologies from Oak Ridge National Laboratory. This positions Marquee to explore downstream processing opportunities for its Redlings REE Project in Western Australia.

Golden Mile Resources Ltd (ASX: G88) has secured a binding joint venture to earn up to 95% interest in the Leviathan Porphyry Copper-Molybdenum Project in Arizona, with initial sampling confirming significant copper and molybdenum mineralisation and exploration set to begin in April 2026.

Mammoth Minerals Limited has reported the identification of several high-grade gold and critical mineral targets at its Excelsior Project in Nevada following a comprehensive 2025 rock chip sampling and mapping program. The company is advancing multiple prospects towards drill readiness with ongoing exploration activities.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Temas Resources Corp has appointed chemical process expert Dr. Santiago Faucher to its Scientific Advisory Board, enhancing the technical and commercialisation capabilities of its Regenerative Chloride Leaching (RCL) technology. This move supports the company’s strategy to advance its innovative hydrometallurgical platform and complements its mineral project developments in Québec.